Globalspace Technologies held its Board of Directors meeting on Friday, May 15, 2026, via video conferencing, wherein the board considered and approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The meeting commenced at 04:26 P.M. and concluded at 08:30 P.M. The results were reviewed by the Audit Committee and taken on record by the board, with statutory auditors Bansilal Shah & Co. expressing an unqualified audit opinion on both standalone and consolidated financial statements. Subsequently, on May 17, 2026, the company filed an intimation with BSE Limited pursuant to Regulation 33 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the publication of its audited financial results in Financial Express (English) and Mumbai Lakshadeep (Marathi).

Standalone Financial Performance

On a standalone basis, Globalspace Technologies reported a significant turnaround for the year ended March 31, 2026. The company posted a net profit after tax of ₹136.49 lacs compared to a net loss of ₹183.73 lacs in the previous year. Total income rose to ₹3,335.63 lacs from ₹2,933.02 lacs, driven by revenue from operations of ₹3,301.35 lacs versus ₹2,932.48 lacs previously. The following table summarises the key standalone financial metrics:

For the quarter ended March 31, 2026, standalone revenue from operations stood at ₹1,050.30 lacs, with net profit after tax of ₹88.18 lacs compared to ₹8.74 lacs in the corresponding quarter of the previous year.

Consolidated Financial Performance

On a consolidated basis, which includes subsidiaries Innopharma Healthcare Private Limited and Miljon Medi App Private Limited, the group reported consolidated revenue from operations of ₹5,146.92 lacs for the year ended March 31, 2026, compared to ₹4,304.58 lacs in the prior year. Consolidated net profit after tax stood at ₹285.23 lacs, reversing a loss of ₹199.92 lacs in the previous year. The key consolidated financials are presented below:

For the quarter ended March 31, 2026, consolidated revenue from operations was ₹1,604.49 lacs, with net profit after tax of ₹245.05 lacs against a loss of ₹15.48 lacs in the year-ago quarter.

Key Balance Sheet and Ratio Highlights

The standalone balance sheet as at March 31, 2026 reflects total assets of ₹6,512.21 lacs, with total equity of ₹5,588.34 lacs compared to ₹5,450.72 lacs in the prior year. On the consolidated front, total assets stood at ₹6,677.56 lacs with total equity of ₹5,695.00 lacs. Key financial ratios showed meaningful improvement, as detailed below:

The auditor's report also noted that an equity commitment towards M/s Miljon Medi App Pvt Ltd of ₹1,144.33 lacs is pending for share allotment in the books as on March 31, 2026.

Corporate Actions: CEO Appointment, Auditor Re-appointment, and ESOP Grant

In addition to the financial results, the board approved several significant corporate actions at the same meeting. The following key decisions were taken:

Ms. Tania Mazumdar is described as a dynamic pharmaceutical and digital health leader with over 22 years of experience across pharmaceutical, diagnostics, and health technology sectors, with expertise in strategic planning, business development, digital transformation, and stakeholder management. She is not related to any director of the company. M/s. Maheshwari Maheshwari & Co., established in 1988, is a Category-I Chartered Accountancy Firm headquartered in Mumbai with a branch in Indore, registered with ICAI (Reg. No. 105838W), CAG (Reg. No. BO0733), and RBI (Unique Code: 064394). The intimation was signed by Krishna Murari Singh, Managing Director, on May 15, 2026, in compliance with Regulation 30 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

GlobalSpace Technologies has announced the launch of PATGPT, a groundbreaking pharmaceutical-specific Large Language Model (LLM) platform, marking a significant milestone in the company's journey towards becoming a leader in AI-driven healthcare solutions.

Hybrid Training Model

PATGPT operates on an innovative hybrid model, with 50% of the training completed by GlobalSpace using pharmaceutical datasets. The remaining 50% will be trained using proprietary data from pharmaceutical companies within their secure cloud environments. This approach positions PATGPT as both a product and a customized LLM training service, allowing pharmaceutical companies to build organization-specific AI intelligence securely.

Initial Focus and Future Applications

In its initial phase, PATGPT will concentrate on optimizing four key areas:

1. Sales
2. Marketing
3. Inventory
4. Distribution

The company has outlined an ambitious roadmap for future applications, including:

• Research and Development (R&D)
• Clinical trials
• Pharmacovigilance
• Regulatory submissions

Strategic Importance

Tania Mazumdar, Executive Director of GlobalSpace Technologies, emphasized the strategic importance of this launch, stating, "The launch of PATGPT marks a significant milestone in GlobalSpace's journey towards becoming a leader in AI-driven healthcare solutions."

New Revenue Streams

The introduction of PATGPT is expected to create new revenue streams for GlobalSpace Technologies through:

1. Product licensing
2. AI training services

About GlobalSpace Technologies Ltd

GlobalSpace Technologies Ltd is a listed digital solutions company that focuses on the healthcare and pharmaceutical sectors. The company provides Software as a Service (SaaS) platforms and AI-powered solutions that enable pharmaceutical companies to:

• Digitize sales force operations
• Strengthen compliance
• Enhance engagement with healthcare professionals

Launch Details

According to the company's LODR filing:

GlobalSpace Technologies Ltd continues to combine deep domain expertise with cutting-edge technology, creating sustainable value for its clients and stakeholders in the pharmaceutical and healthcare sectors.

For more information about PATGPT and GlobalSpace Technologies Ltd, interested parties can visit the company's website at www.globalspace.in or contact them at Info@globalspace.in .